425: Strive & Semler Scientific Merger: Cautionary Update

Strive, Inc. and Semler Scientific, Inc. issued a cautionary statement regarding their proposed business combination, highlighting inherent risks and uncertainties.

Summary

• The communication, a Form 425 filing, was reposted on X.com by Pierre Rochard, a Board Member of Strive, Inc., on December 18, 2025.
• It pertains to Strive's proposed business combination with Semler Scientific, Inc.
• The filing serves as a cautionary statement regarding forward-looking statements related to the proposed transaction, emphasizing inherent risks and uncertainties.
• Key areas of forward-looking statements include the outlook and expectations of both companies, strategic and financial benefits, the timing of closing, and the ability to successfully integrate businesses.
• Investors are cautioned not to rely too heavily on forward-looking statements, as actual results could differ materially from anticipated results.

Sentiment

Score: 5

Explanation: The filing is a standard, legally mandated cautionary statement regarding a proposed merger. Its primary purpose is to inform about risks associated with forward-looking statements, rather than to convey positive or negative operational results. The sentiment is neutral, reflecting a procedural update with necessary risk disclosures.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all due to conditions not being met or satisfied on a timely basis.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The filing discusses the outlook and expectations of Strive and Semler Scientific regarding the proposed transaction, including anticipated strategic and financial benefits, the timing of the closing, and the ability to successfully integrate the combined businesses. However, it heavily emphasizes that these are forward-looking statements subject to significant risks and uncertainties, and actual results may differ materially.

Management Comments

• Pierre Rochard, Board Member of Strive, Inc., reposted this communication on X.com on December 18, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

The filing highlights risks associated with Bitcoin treasury strategies and other digital assets, indicating that the proposed combined entity may have exposure or strategic initiatives related to the evolving digital asset landscape, a significant trend in certain sectors of the financial and technology industries.

Corporate Governance

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock for the merger.
• Customers and employees of both Strive and Semler Scientific may have adverse reactions or changes to their relationships due to the announcement or completion of the proposed transaction.

Next Steps

• Semler Scientific stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus and other relevant documents before making any voting or investment decision.
• The proposed transaction requires approval from Semler Scientific stockholders.
• The closing of the proposed transaction is anticipated, subject to conditions being met.
• Successful integration of the combined businesses is a future objective.

Key Dates

Keywords

Strive, Semler Scientific, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Bitcoin, Digital Assets, Corporate Governance